FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2442282009> ?p ?o ?g. }

• W2442282009 endingPage "113" @default.
• W2442282009 startingPage "97" @default.
• W2442282009 abstract "Human Gene TherapyVol. 12, No. 1 Clinical ProtocolsTreatment of Recurrent or Progressive Malignant Glioma with a Recombinant Adenovirus Expressing Human Interferon-Beta (H5.010CMVhIFN-β): A Phase I TrialPublished Online:6 Jul 2004https://doi.org/10.1089/104303401451013AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byStem Cell Research for the Treatment of Malignant Glioma22 August 2018Novel Delivery Strategies29 December 2016Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor2 April 2015 | Journal of Drug Targeting, Vol. 23, No. 10Clinical trials of viral therapy for malignant gliomas10 January 2014 | Expert Review of Anticancer Therapy, Vol. 13, No. 11Current status of local therapy in malignant gliomas — A clinical review of three selected approachesPharmacology & Therapeutics, Vol. 139, No. 3Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model21 September 2012 | Neurotherapeutics, Vol. 9, No. 4Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies8 February 2012 | Current Respiratory Care Reports, Vol. 1, No. 1An evaluation of site-specific immune responses directed against first-generation adenoviral vectors administered by convection-enhanced delivery7 June 2011 | The Journal of Gene Medicine, Vol. 13, No. 5Gene- and Viral-Based Therapies for GliomasTherapeutic options for recurrent malignant gliomaRadiotherapy and Oncology, Vol. 98, No. 1Cancer Vaccines in Glioma: How to Balance the Challenges of Small Trials, Efficiency, and Potential Adverse EventsJournal of Clinical Oncology, Vol. 28, No. 31Emerging Treatment Modalities II: Gene Therapy for MeningiomasGene Therapy for Neurological Disorders (Except Oncology)Gene Therapy for Malignant Glioma30 July 2009The Development of Targeted Cancer Gene-Therapy Adenoviruses for High-Grade Glioma Treatment20 May 2009Production of the human β-interferon recombinant protein in avian cell culture30 September 2008 | Molecular Genetics, Microbiology and Virology, Vol. 23, No. 3A Phase I Trial of Ad.hIFN-β Gene Therapy for GliomaMolecular Therapy, Vol. 16, No. 3Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cellsJournal of Neurosurgery, Vol. 107, No. 3ADENOVIRAL-MEDIATED GENE TRANSFERINTO THE CANINE BRAIN IN VIVONeurosurgery, Vol. 60, No. 1Prevention of onset of Parkinson’s disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson’s disease22 June 2006 | Gene Therapy, Vol. 13, No. 23Effective High-Capacity Gutless Adenoviral Vectors Mediate Transgene Expression in Human Glioma CellsMolecular Therapy, Vol. 14, No. 3Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus19 September 2006 | Molecular Cancer Therapeutics, Vol. 5, No. 9Novel Gene Therapeutic Approaches to Brain Cancer28 February 2013Cancer gene therapy using a novel secretable trimeric TRAIL29 September 2005 | Gene Therapy, Vol. 13, No. 4Human gene therapy and imaging in neurological diseases23 November 2005 | European Journal of Nuclear Medicine and Molecular Imaging, Vol. 32, No. S2The evolving role of gene-based treatment in surgery4 November 2005 | British Journal of Surgery, Vol. 92, No. 12Gene Therapy For Inherited Diseases Of The Central Nervous System18 December 2009Gene Therapy for Malignant Glioma: Current Clinical StatusMolecular Therapy, Vol. 12, No. 4Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas15 April 2005 | Cancer Research, Vol. 65, No. 8Gene Therapy for Malignant GliomasModification of plasmid DNA-based gene transfer into central nerve systemInternational Congress Series, Vol. 1274Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound22 July 2004 | Gene Therapy, Vol. 11, No. 20Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model13 May 2004 | Gene Therapy, Vol. 11, No. 14Endocrine Aspects of Cancer Gene Therapy31 October 2016 | Endocrine Reviews, Vol. 25, No. 1Expert Review of Anticancer Therapy, Vol. 4, No. 5CANCER GENE THERAPY USING CYTOKINE AND CHEMOKINE GENESAnnals of Cancer Research and Therapy, Vol. 12, No. 1/2Viral Therapy for GlioblastomaThe Cancer Journal, Vol. 9, No. 3Gene Therapy for Human Malignant Brain TumorsThe Cancer Journal, Vol. 9, No. 3Lack of interferon beta–induced radiosensitization in four out of five human glioblastoma cell linesInternational Journal of Radiation Oncology*Biology*Physics, Vol. 55, No. 5Gene therapy of gliomasGene Therapy for Neurological DiseasesJapanese Journal of Neurosurgery, Vol. 12, No. 3Gene Therapy for Lung Cancer25 June 2013IFN-β Gene Transfer into the Central Nervous System Using Bone Marrow Cells as a Delivery System Tapas Kumar Makar, Susan Wilt, Zhongyun Dong, Paul Fishman, M. Maral Mouradian, and Suhayl Dhib-Jalbut7 July 2004 | Journal of Interferon & Cytokine Research, Vol. 22, No. 7Critical Issues in Gene Therapy for Neurologic Disease Gary Hsich, Miguel Sena-Esteves, and Xandra O. Breakefield6 July 2004 | Human Gene Therapy, Vol. 13, No. 5Gene therapy for high grade gliomas23 February 2005 | Expert Opinion on Biological Therapy, Vol. 1, No. 2 Volume 12Issue 1Jan 2001 To cite this article:Treatment of Recurrent or Progressive Malignant Glioma with a Recombinant Adenovirus Expressing Human Interferon-Beta (H5.010CMVhIFN-β): A Phase I Trial.Human Gene Therapy.Jan 2001.97-113.http://doi.org/10.1089/104303401451013Published in Volume: 12 Issue 1: July 6, 2004PDF download" @default.
• W2442282009 created "2016-06-24" @default.
• W2442282009 creator A5000056954 @default.
• W2442282009 creator A5009132849 @default.
• W2442282009 creator A5011536972 @default.
• W2442282009 creator A5014352993 @default.
• W2442282009 creator A5046354916 @default.
• W2442282009 creator A5068349795 @default.
• W2442282009 creator A5074563321 @default.
• W2442282009 creator A5076177583 @default.
• W2442282009 creator A5083803125 @default.
• W2442282009 creator A5088003622 @default.
• W2442282009 creator A5088687918 @default.
• W2442282009 date "2001-01-01" @default.
• W2442282009 modified "2023-10-17" @default.
• W2442282009 title "Treatment of Recurrent or Progressive Malignant Glioma with a Recombinant Adenovirus Expressing Human Interferon-Beta (H5.010CMV<i>hIFN</i>-β): A Phase I Trial" @default.
• W2442282009 cites W1984284981 @default.
• W2442282009 cites W1989669523 @default.
• W2442282009 cites W1996718362 @default.
• W2442282009 cites W2002682635 @default.
• W2442282009 cites W2003494516 @default.
• W2442282009 cites W2009283811 @default.
• W2442282009 cites W2010766782 @default.
• W2442282009 cites W2011486273 @default.
• W2442282009 cites W2014197569 @default.
• W2442282009 cites W2016080258 @default.
• W2442282009 cites W2036364847 @default.
• W2442282009 cites W2049242163 @default.
• W2442282009 cites W2049468392 @default.
• W2442282009 cites W2071772924 @default.
• W2442282009 cites W2072803188 @default.
• W2442282009 cites W2074114618 @default.
• W2442282009 cites W2088925558 @default.
• W2442282009 cites W2144637577 @default.
• W2442282009 cites W2425376529 @default.
• W2442282009 doi "https://doi.org/10.1089/104303401451013" @default.
• W2442282009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11177547" @default.
• W2442282009 hasPublicationYear "2001" @default.
• W2442282009 type Work @default.
• W2442282009 sameAs 2442282009 @default.
• W2442282009 citedByCount "55" @default.
• W2442282009 countsByYear W24422820092012 @default.
• W2442282009 countsByYear W24422820092013 @default.
• W2442282009 countsByYear W24422820092015 @default.
• W2442282009 countsByYear W24422820092016 @default.
• W2442282009 countsByYear W24422820092018 @default.
• W2442282009 crossrefType "journal-article" @default.
• W2442282009 hasAuthorship W2442282009A5000056954 @default.
• W2442282009 hasAuthorship W2442282009A5009132849 @default.
• W2442282009 hasAuthorship W2442282009A5011536972 @default.
• W2442282009 hasAuthorship W2442282009A5014352993 @default.
• W2442282009 hasAuthorship W2442282009A5046354916 @default.
• W2442282009 hasAuthorship W2442282009A5068349795 @default.
• W2442282009 hasAuthorship W2442282009A5074563321 @default.
• W2442282009 hasAuthorship W2442282009A5076177583 @default.
• W2442282009 hasAuthorship W2442282009A5083803125 @default.
• W2442282009 hasAuthorship W2442282009A5088003622 @default.
• W2442282009 hasAuthorship W2442282009A5088687918 @default.
• W2442282009 hasConcept C104317684 @default.
• W2442282009 hasConcept C111599444 @default.
• W2442282009 hasConcept C121608353 @default.
• W2442282009 hasConcept C126322002 @default.
• W2442282009 hasConcept C143998085 @default.
• W2442282009 hasConcept C203014093 @default.
• W2442282009 hasConcept C2777701055 @default.
• W2442282009 hasConcept C2778227246 @default.
• W2442282009 hasConcept C502942594 @default.
• W2442282009 hasConcept C535046627 @default.
• W2442282009 hasConcept C55493867 @default.
• W2442282009 hasConcept C71924100 @default.
• W2442282009 hasConcept C86803240 @default.
• W2442282009 hasConceptScore W2442282009C104317684 @default.
• W2442282009 hasConceptScore W2442282009C111599444 @default.
• W2442282009 hasConceptScore W2442282009C121608353 @default.
• W2442282009 hasConceptScore W2442282009C126322002 @default.
• W2442282009 hasConceptScore W2442282009C143998085 @default.
• W2442282009 hasConceptScore W2442282009C203014093 @default.
• W2442282009 hasConceptScore W2442282009C2777701055 @default.
• W2442282009 hasConceptScore W2442282009C2778227246 @default.
• W2442282009 hasConceptScore W2442282009C502942594 @default.
• W2442282009 hasConceptScore W2442282009C535046627 @default.
• W2442282009 hasConceptScore W2442282009C55493867 @default.
• W2442282009 hasConceptScore W2442282009C71924100 @default.
• W2442282009 hasConceptScore W2442282009C86803240 @default.
• W2442282009 hasIssue "1" @default.
• W2442282009 hasLocation W24422820091 @default.
• W2442282009 hasLocation W24422820092 @default.
• W2442282009 hasOpenAccess W2442282009 @default.
• W2442282009 hasPrimaryLocation W24422820091 @default.
• W2442282009 hasRelatedWork W161918062 @default.
• W2442282009 hasRelatedWork W1977735086 @default.
• W2442282009 hasRelatedWork W1982889774 @default.
• W2442282009 hasRelatedWork W2080368646 @default.
• W2442282009 hasRelatedWork W2139814208 @default.
• W2442282009 hasRelatedWork W2161230988 @default.
• W2442282009 hasRelatedWork W2519868094 @default.
• W2442282009 hasRelatedWork W4231359143 @default.
• W2442282009 hasRelatedWork W4240016344 @default.

• next